NCT03960034View on ClinicalTrials.gov

Cachexia in NSCLC Patients: Diagnosis, Characterization, Prognosis, Functional and Skeletal Muscle Implications

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
NSCLC Stage IV
Trial Locations (1)

01246-000

Instituto do Câncer do Estado de São Paulo, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER

NCT03960034 - Cachexia in NSCLC Patients: Diagnosis, Characterization, Prognosis, Functional and Skeletal Muscle Implications | Biotech Hunter | Biotech Hunter